BeOne Medicines to Invest $300 Million to Expand US Drug Manufacturing

MT Newswires Live
07/23

BeOne Medicines (ONC) said Thursday it plans to invest $300 million to expand its flagship clinical and commercial-stage manufacturing and research and development center at the Princeton West Innovation Campus in Hopewell, New Jersey.

The expansion will advance BeOne's oncology pipeline of more than 35 clinical and commercial-stage assets, the company said.

The investment will fund the construction of a new three-story, 145,000-square-foot building near BeOne's existing Hopewell facilities, increasing the total campus footprint to about 545,000 square feet, the company added.

Price: 322.62, Change: +2.69, Percent Change: +0.84

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10